To provide capital growth.
Name | % Net Assets |
---|---|
Roche Hldgs AG | 5.9% |
Vodafone Group PLC | 5.5% |
Deutsche Telekom AG | 5.0% |
E.ON AG | 4.2% |
BP PLC | 3.1% |
ENI SpA | 3.0% |
Fresenius Medical Care AG | 3.0% |
BAE Systems PLC | 2.9% |
Bayer AG | 2.9% |
Qiagen NV | 2.6% |
Key | % Net Assets |
---|---|
Roche Hldgs AG | 5.9% |
Vodafone Group PLC | 5.5% |
Deutsche Telekom AG | 5.0% |
E.ON AG | 4.2% |
Other | 79.4% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 08/03/2000 |
---|---|
Fund Manager | Thomas Beevers |
TER | - |
Minimum Investment | |
---|---|
Initial | 5000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 2.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.07 |
You are here: research